Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Sustained Immune Complex-Mediated Reduction in CD16 Expression after Vaccination Regulates NK Cell Function
Martin R. Goodier, Chiara Lusa, Sam Sherratt, et al.
Frontiers in Immunology (2016) Vol. 7
Open Access | Times Cited: 60

Showing 1-25 of 60 citing articles:

Comprehensive mapping of immune perturbations associated with severe COVID-19
Leticia Kuri-Cervantes, M. Betina Pampena, Wenzhao Meng, et al.
Science Immunology (2020) Vol. 5, Iss. 49
Open Access | Times Cited: 749
Fc-Mediated Antibody Effector Functions During Respiratory Syncytial Virus Infection and Disease
Elisabeth A. van Erp, Willem Luytjes, Gerben Ferwerda, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 239
Shedding of CD16 disassembles the NK cell immune synapse and boosts serial engagement of target cells
Katja Srpan, Ashley Ambrose, Alexandros Karampatzakis, et al.
The Journal of Cell Biology (2018) Vol. 217, Iss. 9, pp. 3267-3283
Open Access | Times Cited: 139
MOGAD patient autoantibodies induce complement, phagocytosis, and cellular cytotoxicity
Soumya S. Yandamuri, Beata Filipek, Abeer Obaid, et al.
JCI Insight (2023) Vol. 8, Iss. 11
Open Access | Times Cited: 25
CMV and natural killer cells: shaping the response to vaccination
Martin R. Goodier, Stipan Jonjić, Eleanor M. Riley, et al.
European Journal of Immunology (2017) Vol. 48, Iss. 1, pp. 50-65
Open Access | Times Cited: 75
Cellular Immune Function in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
Jacqueline M. Cliff, Elizabeth C. King, Ji‐Sook Lee, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 68
Immunologic perturbations in severe COVID-19/SARS-CoV-2 infection
Leticia Kuri-Cervantes, M. Betina Pampena, Wenzhao Meng, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 59
Functional and Phenotypic Changes of Natural Killer Cells in Whole Blood during Mycobacterium tuberculosis Infection and Disease
Mathieu Garand, Martin R. Goodier, Olumuyiwa Owolabi, et al.
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 53
Fc or not Fc; that is the question: Antibody Fc-receptor interactions are key to universal influenza vaccine design
Sinthujan Jegaskanda, Hillary A. Vanderven, Adam K. Wheatley, et al.
Human Vaccines & Immunotherapeutics (2017) Vol. 13, Iss. 6, pp. 1288-1296
Open Access | Times Cited: 51
Human Cytomegalovirus Antigen Presentation by HLA-DR+ NKG2C+ Adaptive NK Cells Specifically Activates Polyfunctional Effector Memory CD4+ T Lymphocytes
Marcel Costa-García, Michelle Ataya, Manuela Moraru, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 46
Peripheral natural killer cells in chronic hepatitis B patients display multiple molecular features of T cell exhaustion
Marie Marotel, Marine Villard, Annabelle Drouillard, et al.
eLife (2021) Vol. 10
Open Access | Times Cited: 38
Eosinophils and COVID‐19: Insights into immune complexity and vaccine safety
W. Sahli, Joana Vitte, Benoît Desnues
Clinical and Translational Allergy (2025) Vol. 15, Iss. 3
Open Access
Transcriptomic signatures of NK cells suggest impaired responsiveness in HIV-1 infection and increased activity post-vaccination
Margaret C. Costanzo, Dohoon Kim, Matthew Creegan, et al.
Nature Communications (2018) Vol. 9, Iss. 1
Open Access | Times Cited: 45
Natural killer cells as a therapeutic tool for infectious diseases - current status and future perspectives
Stanislaw Schmidt, Lars Tramsen, Bushra Rais, et al.
Oncotarget (2018) Vol. 9, Iss. 29, pp. 20891-20907
Open Access | Times Cited: 38
Deregulated cellular circuits driving immunoglobulins and complement consumption associate with the severity of COVID‐19 patients
Ana Marcos‐Jiménez, Santiago Sánchez‐Alonso, Ana Alcaraz‐Serna, et al.
European Journal of Immunology (2020) Vol. 51, Iss. 3, pp. 634-647
Open Access | Times Cited: 36
Considerations of Antibody Geometric Constraints on NK Cell Antibody Dependent Cellular Cytotoxicity
Charles D. Murin
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 32
Identifying SARS‐CoV‐2 ‘memory’ NK cells from COVID‐19 convalescent donors for adoptive cell therapy
Lara Herrera, Myriam Martin‐Inaraja, Silvia J. Santos, et al.
Immunology (2021) Vol. 165, Iss. 2, pp. 234-249
Open Access | Times Cited: 29
Phenotypic Heterogeneity of Dysfunctional Natural Killer Cells During Chronic Infection or Cancer
Kévin Pouxvielh, Marie Marotel, Noëmi Rousseaux, et al.
Springer eBooks (2025), pp. 1-31
Closed Access
Mass Cytometry Analytical Approaches Reveal Cytokine‐Induced Changes in Natural Killer Cells
Elena Vendrame, Julia Fukuyama, Dara M. Strauss‐Albee, et al.
Cytometry Part B Clinical Cytometry (2016) Vol. 92, Iss. 1, pp. 57-67
Open Access | Times Cited: 37
Hepatitis C virus-induced NK cell activation causes metzincin-mediated CD16 cleavage and impaired antibody-dependent cytotoxicity
Barbara Oliviero, Stefania Mantovani, Stefania Varchetta, et al.
Journal of Hepatology (2017) Vol. 66, Iss. 6, pp. 1130-1137
Closed Access | Times Cited: 36
KSHV infection drives poorly cytotoxic CD56-negative natural killer cell differentiation in vivo upon KSHV/EBV dual infection
Nicole Caduff, Donal McHugh, Lisa Rieble, et al.
Cell Reports (2021) Vol. 35, Iss. 5, pp. 109056-109056
Open Access | Times Cited: 24
Recruited and Tissue-Resident Natural Killer Cells in the Lung During Infection and Cancer
Miriam Franklin, Emma Connolly, Tracy Hussell
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 17
Autologous dendritic cell vaccination against HIV-1 induces changes in natural killer cell phenotype and functionality
Thessa Laeremans, Sabine den Roover, Cynthia Lungu, et al.
npj Vaccines (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 10
Enhancement of cytokine‐driven NK cell IFN‐γ production after vaccination of HCMV infected Africans
Alansana Darboe, Ebrima Danso, Ed Clarke, et al.
European Journal of Immunology (2017) Vol. 47, Iss. 6, pp. 1040-1050
Open Access | Times Cited: 29
Vaccinating for natural killer cell effector functions
Helen R. Wagstaffe, Jason P. Mooney, Eleanor M. Riley, et al.
Clinical & Translational Immunology (2018) Vol. 7, Iss. 1
Open Access | Times Cited: 29
Page 1 - Next Page

Scroll to top